文献速递其他结缔组织病

原发性干燥综合征患者死亡率:系统综述与荟萃分析

Mortality in patients with primary Sjögren's syndrome: a systematic review and meta-analysis.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

与一般人群相比,pSS患者全因死亡风险升高46%(meta-SMR:1.46,95%CI:1.10,1.93),老年、男性、血管炎、间质性肺病、低补体、抗La/SSB阳性及冷球蛋白血症患者死亡风险更高。

要点

  • pSS患者全因死亡风险较一般人群升高46%(meta-SMR:1.46,95%CI:1.10,1.93)。
  • 欧洲国家、回顾性研究、转诊队列、样本量>500及随访>8年的研究亚组死亡风险更高。
  • 老年、男性、血管炎、间质性肺病、低补体、抗La/SSB阳性及冷球蛋白血症提示死亡风险更高。

核心结论

  • 现有数据表明pSS患者死亡率较一般人群约增加50%,应更多关注具有不良预后因素的患者。

主要发现

  • 与一般人群相比,pSS患者全因死亡风险升高(meta-SMR:1.46,95%CI:1.10,1.93)。
  • 欧洲国家研究亚组死亡风险升高(meta-SMR:1.55,95%CI:1.04,2.33)。
  • 回顾性研究亚组死亡风险升高(meta-SMR:1.50,95%CI:1.09,2.05)。
  • 转诊队列研究亚组死亡风险升高(meta-SMR:1.55,95%CI:1.04,2.30)。
  • 纳入>500例患者的研究亚组死亡风险升高(meta-SMR:1.70,95%CI:1.11,2.61)。

关键数值与推荐

  • 随访时间>8年的研究亚组meta-SMR为1.55(95%CI:0.87,2.77)。
  • 老年、男性、血管炎、间质性肺病、低补体、抗La/SSB阳性及冷球蛋白血症患者死亡风险显著更高。

临床怎么用

  • 对pSS患者应关注老年、男性、合并血管炎、间质性肺病、低补体、抗La/SSB阳性及冷球蛋白血症等不良预后因素,加强监测与管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: It remains debated whether patients with primary Sjögren's syndrome (pSS) are at greater risk of mortality. We aimed to determine the magnitude of all-cause mortality risk in patients with pSS compared with the general population through a systematic review and meta-analysis. METHODS: We searched PubMed, EMBASE and Cochrane Library for studies published from inception to October 2020. Stata meta-analysis software was used to calculate the pooled risk estimates for mortality (standardized mortality ratio, SMR). RESULTS: Our search identified 2796 articles, of which 14 studies with 14 584 patients were eventually included for the analysis. A total of 902 deaths were observed. Overall, we found a 1.46-fold increased risk of death in pSS patients when compared with the general population [meta-standardized mortality ratio (SMR): 1.46, 95% CI: 1.10, 1.93]. Subgroup analyses showed that mortality risks were higher in European countries (meta-SMR: 1.55, 95% CI: 1.04, 2.33), in retrospective studies (meta-SMR: 1.50, 95% CI: 1.09, 2.05), in studies based on referral cohorts (meta-SMR: 1.55, 95% CI: 1.04, 2.30), in studies that enrolled >500 patients (meta-SMR: 1.70, 95% CI: 1.11, 2.61) and in studies with follow-up time longer than 8 years (meta-SMR: 1.55, 95% CI: 0.87, 2.77). Significantly greater mortality risk was found in patients with older age, male gender, vasculitis, interstitial lung disease, low complements, positive anti-La/SSB and cryoglobulinaemia. CONCLUSION: The existing data indicated ∼50% increase of mortality among patients with pSS compared with the general population. More attention should be paid to those patients with poor prognostic factors.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Huang H, Xie W, Geng Y, et al. Mortality in patients with primary Sjögren's syndrome: a systematic review and meta-analysis. Rheumatology (Oxford). 2021. PMID: 33878179. doi:10.1093/rheumatology/keab364

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。